BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16528046)

  • 61. Mapping of nucleocapsid residues important for HIV-1 genomic RNA dimerization and packaging.
    Kafaie J; Song R; Abrahamyan L; Mouland AJ; Laughrea M
    Virology; 2008 Jun; 375(2):592-610. PubMed ID: 18343475
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Structural and dynamic characterization of the aromatic amino acids of the human immunodeficiency virus type I nucleocapsid protein zinc fingers and their involvement in heterologous tRNA(Phe) binding: a steady-state and time-resolved fluorescence study.
    Mély Y; Piémont E; Sorinas-Jimeno M; de Rocquigny H; Jullian N; Morellet N; Roques BP; Gérard D
    Biophys J; 1993 Oct; 65(4):1513-22. PubMed ID: 8274645
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of distal zinc finger of nucleocapsid protein in genomic RNA dimerization of human immunodeficiency virus type 1; no role for the palindrome crowning the R-U5 hairpin.
    Laughrea M; Shen N; Jetté L; Darlix JL; Kleiman L; Wainberg MA
    Virology; 2001 Mar; 281(1):109-16. PubMed ID: 11222101
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro.
    Schmalzbauer E; Strack B; Dannull J; Guehmann S; Moelling K
    J Virol; 1996 Feb; 70(2):771-7. PubMed ID: 8551614
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity.
    Ottmann M; Gabus C; Darlix JL
    J Virol; 1995 Mar; 69(3):1778-84. PubMed ID: 7853517
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection.
    Freed EO; Englund G; Martin MA
    J Virol; 1995 Jun; 69(6):3949-54. PubMed ID: 7745752
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation.
    Joshi A; Nagashima K; Freed EO
    J Virol; 2006 Aug; 80(16):7939-51. PubMed ID: 16873251
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A binding shift assay for the zinc-bound and zinc-free HIV-1 nucleocapsid protein by capillary electrophoresis.
    Guszczynski T; Copeland TD
    Anal Biochem; 1998 Jul; 260(2):212-7. PubMed ID: 9657880
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of HIV type 1 protease, reverse transcriptase, cleavage site, and p6 mutations on the virological response to quadruple therapy with saquinavir, ritonavir, and two nucleoside analogs.
    Kaufmann GR; Suzuki K; Cunningham P; Mukaide M; Kondo M; Imai M; Zaunders J; Cooper DA
    AIDS Res Hum Retroviruses; 2001 Apr; 17(6):487-97. PubMed ID: 11350662
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication.
    Lee SK; Nagashima K; Hu WS
    J Virol; 2005 Apr; 79(7):4159-69. PubMed ID: 15767417
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Characterization of human immunodeficiency virus type 1 (HIV-1) containing mutations in the nucleocapsid protein at a putative HIV-1 protease cleavage site.
    Thomas JA; Shulenin S; Coren LV; Bosche WJ; Gagliardi TD; Gorelick RJ; Oroszlan S
    Virology; 2006 Oct; 354(2):261-70. PubMed ID: 16904152
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Amino acid insertions near Gag cleavage sites restore the otherwise compromised replication of human immunodeficiency virus type 1 variants resistant to protease inhibitors.
    Tamiya S; Mardy S; Kavlick MF; Yoshimura K; Mistuya H
    J Virol; 2004 Nov; 78(21):12030-40. PubMed ID: 15479842
    [TBL] [Abstract][Full Text] [Related]  

  • 73. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
    Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The roles of the human immunodeficiency virus type 1 Pol protein and the primer binding site in the placement of primer tRNA(3Lys) onto viral genomic RNA.
    Liang C; Rong L; Morin N; Cherry E; Huang Y; Kleiman L; Wainberg MA
    J Virol; 1997 Dec; 71(12):9075-86. PubMed ID: 9371564
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Regulation of intracellular human immunodeficiency virus type-1 protease activity.
    Gatlin J; Arrigo SJ; Schmidt MG
    Virology; 1998 Apr; 244(1):87-96. PubMed ID: 9581782
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Transmission electron microscopy reveals an optimal HIV-1 nucleocapsid aggregation with single-stranded nucleic acids and the mature HIV-1 nucleocapsid protein.
    Mirambeau G; Lyonnais S; Coulaud D; Hameau L; Lafosse S; Jeusset J; Justome A; Delain E; Gorelick RJ; Le Cam E
    J Mol Biol; 2006 Dec; 364(3):496-511. PubMed ID: 17020765
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.
    Ono A; Freed EO
    J Virol; 1999 May; 73(5):4136-44. PubMed ID: 10196310
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle.
    Enssle J; Fischer N; Moebes A; Mauer B; Smola U; Rethwilm A
    J Virol; 1997 Oct; 71(10):7312-7. PubMed ID: 9311808
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Determinants of activity of the HIV-1 maturation inhibitor PA-457.
    Li F; Zoumplis D; Matallana C; Kilgore NR; Reddick M; Yunus AS; Adamson CS; Salzwedel K; Martin DE; Allaway GP; Freed EO; Wild CT
    Virology; 2006 Dec 5-20; 356(1-2):217-24. PubMed ID: 16930665
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dominant Negative MA-CA Fusion Protein Is Incorporated into HIV-1 Cores and Inhibits Nuclear Entry of Viral Preintegration Complexes.
    Anderson-Daniels J; Singh PK; Sowd GA; Li W; Engelman AN; Aiken C
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.